The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.
Pharmacological Inhibition of mTORC1 Suppresses Anatomical, Cellular, and Behavioral Abnormalities in Neural-Specific Pten Knock-Out Mice
Open accessAbstract
PTEN (phosphatase and tensin homolog deleted on chromosome ten) is a lipid phosphatase that counteracts the function of phosphatidylinositol-3 kinase (PI3K). Loss of function of PTEN results in constitutive activation of AKT and downstream effectors and correlates with many human cancers, as well as various brain disorders, including macrocephaly, seizures, Lhermitte–Duclos disease, and autism. We previously generated a conditional Pten knock-out mouse line with Pten loss in limited postmitotic neurons in the cortex and hippocampus.Pten-null neurons developed neuronal hypertrophy and loss of neuronal polarity. The mutant mice exhibited macrocephaly and behavioral abnormalities reminiscent of certain features of human autism. Here, we report that rapamycin, a specific inhibitor of mammalian target of rapamycin complex 1 (mTORC1), can prevent and reverse neuronal hypertrophy, resulting in the amelioration of a subset of PTEN-associated abnormal behaviors, providing evidence that the mTORC1 pathway downstream of PTEN is critical for this complex phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally in animal models of autism spectrum disorder (ASD), altered mTORC1 signaling contributes to the observed synaptic dysfunction and aberrant network connectivity (13,15,(21)(22)(23)(24)(25)(26)(27).”
From Analysis of proteins that rapidly change upon mechanistic/mammalian target of rapamycin complex 1 (mTORC1) repression identifies parkinson protein 7 (PARK7) as a novel protein aberrantly expressed in tuberous sclerosis complex (TSC) (2016) · cites this paper as [21]
Experimental — accuracy not yet measuredIn the citing paper
“Notably, pharmacological and genetic manipulations have successfully rescued both structural and behavioral phenotypes in PTEN86, FMR1 (ref. 87) and MECP2 (ref. 88) knockout mice.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [86]
In the citing paper
“That behavioral recovery in each of these rescue strategies was paralleled by reversal of spine pathologies underscores the importance of these structural perturbations in the pathogenesis of ASDs and comorbid disorders and the potential for the use of animal models in the development of therapeutics.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [86]
In the citing paper
“Rapamycin successfully reduced cognitive impairment and social behavior deficit in mouse models of tuberous sclerosis 61-63 and improved behavior in adult mice with a deletion of PTEN 64 .”
From Progress toward treatments for synaptic defects in autism (2013) · cites this paper as [64]
In the citing paper
“Experimental interventions, working through diverse genetic and pharmacological mechanisms, rescue subsets of behavioral abnormalities in these mouse models (31, 43, 48–52).”
From Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism (2012) · cites this paper as [52]
In the citing paper
“Target strategies draw from therapeutics under investigation for other neurodevelopmental disorders and hypotheses emerging from mutations in synaptic genes identified in small numbers of individuals with autism spectrum disorders (43, 49, 52).”
From Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism (2012) · cites this paper as [52]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
Generalized lacZ expression with the ROSA26 Cre reporter strain
Soriano, P. (1999) · Nature Genetics · doi:10.1038/5007 · Cited by 5,237
Narcolepsy in orexin Knockout Mice
Chemelli, R. M., Willie, J. T., Sinton, C. M., Elmquist, J. K., Scammell, T., Lee, C., Richardson, J. A., Williams, S. C., Xiong, Y., Kisanuki, Y., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)81973-x · Cited by 3,095
Self-citationTSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J.-H., Hsu, P. P., Bagley, A. F., Markhard, A. L., & Sabatini, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.029 · Cited by 2,365
Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast
Heitman, J., Movva, N. R., & Hall, M. N. (1991) · Science · doi:10.1126/science.1715094 · Cited by 2,010
Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J., & Cantley, L. C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00568-3 · Cited by 1,555
Pten Regulates Neuronal Arborization and Social Interaction in Mice
Kwon, C.-H., Luikart, B. W., Powell, C. M., Zhou, J., Matheny, S. A., Zhang, W., Li, Y., Baker, S. J., & Parada, L. F. (2006) · Neuron · doi:10.1016/j.neuron.2006.03.023 · Cited by 970
Self-citationAkt regulates growth by directly phosphorylating Tsc2
Potter, C. J., Pedraza, L. G., & Xu, T. (2002) · Nature Cell Biology · doi:10.1038/ncb840 · Cited by 959
Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis
Ehninger, D., Han, S., Shilyansky, C., Zhou, Y., Li, W., Kwiatkowski, D. J., Ramesh, V., & Silva, A. J. (2008) · Nature Medicine · doi:10.1038/nm1788 · Cited by 882
Cited by
Sorted by citations
Items 401–441 of 441
Ucha, M., Coria, S. M., Núñez, A. E., Santos‐Toscano, R., Roura‐Martínez, D., Fernández‐Ruíz, J., Higuera‐Matas, A., & Ambrosio, E. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/276121
Dechandt, C. R. P. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2018.tde-13092018-104230
Wheeler, R. V. (2018) · DalSpace (Dalhousie University)
Genetics of autism spectrum disorders
Gupta, A. R., Fernandez, T. V., & Hoffman, E. J. (2020) · doi:10.1093/med/9780198713005.003.0028
Approach to the Treatment of Medication-Resistant Epilepsy
Stern, J. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316492376.015
Hippocampal Sclerosis as a Cause of Medication-Resistant Epilepsy
Chowdhury, F. A., Diehl, B., & Thom, M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316492376.011
Genetic Causes of Medication-Resistant Epilepsy
Ferraro, T. N., Fischer, B. D., & Buono, R. J. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316492376.009
International League Against Epilepsy’s Definition of Medication-Resistant Epilepsy
Josephson, C. B., & Wiebe, S. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316492376.003
Neurobiology of Medication-Resistant Epilepsy
Engel, J. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316492376.008
Models for Medication-Resistant Epilepsy
Sankar, R. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316492376.007
Mortality and Morbidity of Medication-Resistant Epilepsy
Lacuey, N., & Lhatoo, S. D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316492376.006
Challenges in Identifying Medication-Resistant Epilepsy
Brodie, M. J., & Auce, P. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316492376.002
Malformations of Cortical Development as Causes of Medication-Resistant Epilepsy
Kuzniecky, R. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316492376.010
Reproductive Health for Women with Medication-Resistant Epilepsy
Yoo, J. Y., & Harden, C. L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316492376.017
Autoimmune Causes of Medication-Resistant Epilepsy
Feyissa, A. M., & Britton, J. W. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316492376.012
Resective Surgery for Medication-Resistant Epilepsy
Jobst, B. C., & Bujarski, K. A. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316492376.018
Ablative Surgery for Medication-Resistant Epilepsy
Hoelscher, C. M., Atsina, K., Wu, C., & Sharan, A. D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316492376.019
Diet Therapy for Medication-Resistant Epilepsy
Kossoff, E. H., & Lowenstein, D. B. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316492376.021
Botanical Treatments for Medication-Resistant Epilepsy
Schachter, S. C. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316492376.022
Silva, A. L. T. E. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.41.2020.tde-30112020-001426
Stimulation Treatment for Medication-Resistant Epilepsy
Stern, J. M., Sankar, R., & Sperling, M. R. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316492376.020
Stern, J. M., Sankar, R., & Sperling, M. R. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316492376.024
Cullen, E. R., Mittelstadt, I., & Weston, M. C. (2023) · eLife · doi:10.7554/elife.91323.1
Nguyen, L. H., Xu, Y., Nair, M., & Bordey, A. (2024) · eLife · doi:10.7554/elife.91010.2
Cullen, E. R., Safari, M., Mittelstadt, I., & Weston, M. C. (2024) · eLife · doi:10.7554/elife.91323.2.sa4
Eslamizade, M. J., Saffarzadeh, F., & Aguilar‐Valles, A. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.12.033
The Role of the New mTOR Complex, MTORC2, in Autism Spectrum Disorders
Costa‐Mattioli, M. (2014) · Defense Technical Information Center (DTIC) · doi:10.21236/ada613836
Sarn, N., Thacker, S., Lee, H., & Eng, C. (2021) · Figshare · doi:10.6084/m9.figshare.14736951
Kang, S. C., Jaini, R., Hitomi, M., Lee, H., Sarn, N., Thacker, S., & Eng, C. (2020) · Figshare · doi:10.6084/m9.figshare.12414263
Repurposing drugs for treating the neurobehavioral manifestations of PTEN hamartoma tumor syndrome
Fieblinger, T., Rudolph, J., Müller, K., Friess, P., Weigelt, N., Thiede, C., Modolo, S., Federico, D., Majandinow, M., Tinarelli, F., et al. (2026) · iScience · doi:10.1016/j.isci.2026.115428
In-vivo studies of malformations of cortical development associated with mutations in TUBG1
Ivanova, E. L. (2018) · theses.fr (ABES) · doi:10.70675/55c08bacz3dcfz4824zb7aczb5ab9dcc8304
Pineau, L. (2023) · theses.fr (ABES) · doi:10.70675/39c790cfzdf57z416bzb9cez06eca43d9cda
Xu, J., Xu, L., Li, Y., Kong, X., Ma, W., Xie, L., Lyu, Y., & Xuan, A. (2026) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.70953
mTORC2-Na v 1.2 signaling drives early hyperexcitability in Alzheimer’s disease mouse model
Dvorak, N. M., & Noebels, J. L. (2026) · Channels · doi:10.1080/19336950.2026.2687246
Scaling of Neuronal Growth and Excitability Through Separable mTORC1 and mTORC2 PathwaysPreprint
Abdulkareem, A. F., Elste, N., Younger, R., Prina, M. L., Dennis, E., Urbanczyk, J. M., Bayat, M., Malik, H. A., Tafti, S. A., Holoubek, H. S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.22.733785
Belle, J. E. L., Condro, M. C., Cepeda, C., Oikonomou, K. D., Tessema, K. K., Dudley, L., Schoenfield, J., Kawaguchi, R., Geschwind, D. H., Silva, A. J., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-74958-1 · Cited by 2
Erdem, C., Thomson, S. R., Bahey, N. G., Selfridge, J., Kendall, T. J., Cobb, S., & Gadalla, K. K. E. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18080922
PHGDH-derived serine is essential for vascular remodeling after stroke
Liu, Z., Liu, C., Du, P., Geng, X., Wang, S., Wang, Z., Huang, Y., Chang, L., Wang, Y.-C., Fan, W., et al. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.09.004
Melin, J. M., Young, N. A., & Camardo, J. S. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261495936
Lee, C.-H., Hong, J.-P., Lim, S.-N., Li, T.-E., Liao, T.-W., Chang, C.-W., Chen, B.-X., & Chen, H. (2026) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2026.102965
Metadata
- Authors
- Zhou, J., Blundell, J., Ogawa, S., Kwon, C.-H., Zhang, W., Sinton, C., Powell, C. M., & Parada, L. F.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- The University of Texas at Dallas (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2009-02-11
- Volume
- 29
- Issue
- 6
- Pages
- 1773-1783
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC3904448
- OpenAlex
- W2017097994
- Cited by
- 441
- References
- 52
- Citations by year
- 2026: 10 · 2025: 20 · 2024: 17 · 2023: 17 · 2022: 19 · 2021: 22 · 2020: 49 · 2019: 16 · 2018: 24 · 2017: 28 · 2016: 22 · 2015: 37 · 2014: 31 · 2013: 32 · 2012: 39
- FWCI
- 12.74
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- Funders
- Autism Speaks (AS1270, AS2126)
- Simons Foundation
- National Institute of Mental Health (K08MH065975, R01MH081164)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R21HD065290)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Keywords
- PTEN, mTORC1, rapamycin, neuronal hypertrophy, neuronal polarity, macrocephaly, autism-like behavior, postmitotic neurons, PI3K/Akt signaling, Lhermitte-Duclos disease, seizures, hippocampus, cortex
- MeSH terms
- Animals, Autistic Disorder, Female, Male, Mice, Inbred C57BL, Neurons, Transcription Factors, Mice, Knockout, Sirolimus, PTEN Phosphohydrolase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
